Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Blau

Showing results (61-70 of 129) with videos related to

Pageof 13
Sort By:
Haematologica|August 16, 2000
Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysisM Bornhäuser, C Theuser, S Soucek, et al.
Journal of Nanoscience and Nanotechnology|February 10, 2009
Growth of carbon nanotubes on Si substrate using Fe catalyst produced by pulsed laser depositionS Krishnamurthy, T Donnelly, N McEvoy, et al.
Journal of Pain and Symptom Management|April 1, 1995
Managing cancer pain: content and scope of an educational program for nurses who work in predominantly rural areasJ A Dalton, S Bernard, W Blau, et al.
International Journal of Hematology|September 19, 2007
Intensified strategies to control vancomycin-resistant enterococci in immunocompromised patientsM Schmidt-Hieber, I W Blau, S Schwartz, et al.
Bone Marrow Transplantation|March 13, 2001
Feasibility and safety of peripheral blood stem cell transplantation from unrelated donors: results of a single-center studyI W Blau, N Basara, G Lentini, et al.
Blood Cancer Journal|February 28, 2021
Polymorphisms in CXCR3 ligands predict early CXCL9 recovery and severe chronic GVHDHao Dai, Sivaramakrishna P Rachakonda, Olaf Penack, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 11, 2022
Real-World Efficacy of Nintedanib Plus Docetaxel After Progression on Immune Checkpoint Inhibitors: Results From the Ongoing, Non-interventional VARGADO StudyC Grohé, W Blau, W Gleiber, et al.
Leukemia & Lymphoma|December 3, 2005
Allogeneic hematopoietic cell transplantation following conditioning with 90Y-ibritumomab-tiuxetanT Fietz, L Uharek, C Gentilini, et al.
Cancer Genetics and Cytogenetics|April 6, 2010
Cytogenetic studies in acute leukemia patients relapsing after allogeneic stem cell transplantationMartin Schmidt-Hieber, Igor W Blau, Gregor Richter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2000
Toxoplasmosis, a severe complication in allogeneic hematopoietic stem cell transplantation: successful treatment strategies during a 5-year single-center experienceE Roemer, I W Blau, N Basara, et al.
Pageof 13

Showing results (61-70 of 129) with videos related to

Sort By:
Pageof 13
Haematologica|August 16, 2000
Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysisM Bornhäuser, C Theuser, S Soucek, et al.
Journal of Nanoscience and Nanotechnology|February 10, 2009
Growth of carbon nanotubes on Si substrate using Fe catalyst produced by pulsed laser depositionS Krishnamurthy, T Donnelly, N McEvoy, et al.
Journal of Pain and Symptom Management|April 1, 1995
Managing cancer pain: content and scope of an educational program for nurses who work in predominantly rural areasJ A Dalton, S Bernard, W Blau, et al.
International Journal of Hematology|September 19, 2007
Intensified strategies to control vancomycin-resistant enterococci in immunocompromised patientsM Schmidt-Hieber, I W Blau, S Schwartz, et al.
Bone Marrow Transplantation|March 13, 2001
Feasibility and safety of peripheral blood stem cell transplantation from unrelated donors: results of a single-center studyI W Blau, N Basara, G Lentini, et al.
Blood Cancer Journal|February 28, 2021
Polymorphisms in CXCR3 ligands predict early CXCL9 recovery and severe chronic GVHDHao Dai, Sivaramakrishna P Rachakonda, Olaf Penack, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 11, 2022
Real-World Efficacy of Nintedanib Plus Docetaxel After Progression on Immune Checkpoint Inhibitors: Results From the Ongoing, Non-interventional VARGADO StudyC Grohé, W Blau, W Gleiber, et al.
Leukemia & Lymphoma|December 3, 2005
Allogeneic hematopoietic cell transplantation following conditioning with 90Y-ibritumomab-tiuxetanT Fietz, L Uharek, C Gentilini, et al.
Cancer Genetics and Cytogenetics|April 6, 2010
Cytogenetic studies in acute leukemia patients relapsing after allogeneic stem cell transplantationMartin Schmidt-Hieber, Igor W Blau, Gregor Richter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2000
Toxoplasmosis, a severe complication in allogeneic hematopoietic stem cell transplantation: successful treatment strategies during a 5-year single-center experienceE Roemer, I W Blau, N Basara, et al.
Pageof 13